Clinical Trial Update: Validation of the MiCK Assay

View source ↗

Summary

The MiCK Assay validation trial (NCT01770665) sponsored by Pierian Biosciences has been terminated, involving mesothelioma, small cell lung cancer, and non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Pierian Biosciences | Conditions: Mesothelioma, Small Cell Lung Cancer, NSCLC | Status: TERMINATED